Question 1

What is Elicio Therapeutics?

Accepted Answer

Elicio Therapeutics is a Company.

Question 2

How often does Elicio Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Elicio Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 25, 2026.

Question 4

When was Elicio Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 29, 2026.

Question 5

What is Elicio Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: -90 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Elicio Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Elicio Therapeutics?

Accepted Answer

Elicio Therapeutics Securities Fraud Investigation (Jun 25, 2026, 6 articles).

Question 8

How did the "Elicio Therapeutics Securities Fraud Investigation" event impact Elicio Therapeutics?

Accepted Answer

Elicio Therapeutics is under investigation for potential securities fraud after its stock price plummeted due to negative clinical trial results for its ELI-002 7P drug. This event significantly impacts its reputation and financial standing.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.